Innovative and Productive Pharmaceutical Research Through Strategic Capability ManagementA research and development series for life sciences |
|
Research and Development (R&D) in life sciences, especially on a global scale, is difficult to manage. For many companies, the struggle to maintain a sustainable pipeline and drive growth while controlling costs has resulted in fragmented, unwieldy R&D organizations and inadequate results. Life sciences companies that learn to manage R&D as an integrated set of capabilities become more agile, efficient and better positioned to innovate in a changing industry.
This article describes Deloitte’s capabilities-based view of R&D that has allowed life sciences companies to better understand the strengths and challenges of each component of their R&D organization. This methodology is designed to help executives align R&D activities to their strategic business objectives.
Download the full article below.
Last updated
Innovative and Productive Pharmaceutical Research through Strategic Capability Management
(2225.00 KB)
